EMEA-000816-PIP02-10-M02

Key facts

Invented name
Izinova (and associated names)
Active substance
  • Sodium sulphate
  • potassium sulphate
  • magnesium sulphate heptahydrate (BLI800)
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0035/2019
PIP number
EMEA-000816-PIP02-10-M02
Pharmaceutical form(s)
Oral solution
Condition(s) / indication(s)
Diagnostic of organic and/or functional bowel diseases
Route(s) of administration
Oral use
Contact for public enquiries
IPSEN Pharma

Tel.  +33 158335500
E-mail: ch_ra@ipsen.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating